Wesley Hills, NY, United States of America

Bin Xu

USPTO Granted Patents = 2 

Average Co-Inventor Count = 7.5

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2011-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Bin Xu

Introduction

Bin Xu is a notable inventor based in Wesley Hills, NY (US), recognized for his significant contributions to the field of biopharmaceuticals. With a total of two patents to his name, he has made strides in developing compounds that target viral infections, particularly Hepatitis C.

Latest Patents

Xu's latest patents include innovative compounds that have the potential to revolutionize treatment methods. The first patent focuses on pyrazole compounds, specifically aryl substituted pyrazole derivatives. This invention outlines processes for their preparation and provides compositions and methods for treating Hepatitis C virus (HCV) by administering these compounds, either alone or in combination with additional antiviral agents. The second patent pertains to 3,4-disubstituted coumarin and quinolone compounds. This invention relates to derivatives of these compounds and their preparation processes, as well as methods for treating HCV infections through the administration of these derivatives.

Career Highlights

Bin Xu is associated with XTL Biopharmaceuticals Ltd., where he applies his expertise in drug development and innovation. His work has contributed to advancing therapeutic options for patients suffering from viral infections.

Collaborations

Throughout his career, Xu has collaborated with talented individuals such as Yixin Liu and Anthony Sandrasagra, enhancing the research and development efforts within his field.

Conclusion

Bin Xu's innovative work in developing antiviral compounds showcases his commitment to improving healthcare solutions. His contributions are vital in the ongoing battle against viral infections, particularly Hepatitis C.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…